Financial statements Naukowa Polpharmy
Balance sheet data of NAUKOWA POLPHARMY
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|
Total assets | 1 751 411,67 | 1 915 208,75 | 1 526 579,51 | 2 206 000,92 | 754 642,46 |
A. Fixed assets | 0,00 | 0,00 | 0,00 | 108 808,87 | 224 874,74 |
B. Current assets | 1 751 411,67 | 1 915 208,75 | 1 526 579,51 | 2 097 192,05 | 529 767,72 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
D. Own shares (stocks) | - | - | - | - | - |
Total liabilities | 1 751 411,67 | 1 915 208,75 | 1 526 579,51 | 2 206 000,92 | 754 642,46 |
A. Equity | 1 655 259,29 | 1 908 116,86 | 1 386 230,52 | 1 426 635,96 | 682 091,03 |
B. Liabilities and provisions for liabilities | 96 152,38 | 7 091,89 | 140 348,99 | 779 364,96 | 72 551,43 |
I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
II. Short-term liabilities | 96 152,38 | 7 091,89 | 140 348,99 | 779 364,96 | 72 551,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.